Literature DB >> 8382964

Successful treatment of Trypanosoma cruzi encephalitis in a patient with hemophilia and AIDS.

A Solari1, H Saavedra, C Sepúlveda, D Oddó, G Acuña, J Labarca, S Muñoz, G Cuny, C Brengues, F Veas.   

Abstract

Although the frequency of infection with the human immunodeficiency virus (HIV) is increasing dramatically in areas where Trypanosoma cruzi is endemic, trypanosomiasis has been rarely reported in persons with HIV infection or AIDS. Persons with hemophilia who receive multiple blood product transfusions from blood banks with little or no screening for infectious agents are at particularly high risk for infections with both HIV and T. cruzi. We describe the case of a person with hemophilia who was infected by blood transfusion with HIV and T. cruzi and in whom a multifocal, necrotic trypanosomal encephalitis was demonstrated by brain biopsy and electron microscopy. Treatment with benznidazole followed by that with itraconazole and fluconazole was associated with significant clinical and radiographic improvement.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382964     DOI: 10.1093/clind/16.2.255

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  5 in total

1.  Absence of CD4+ T lymphocytes, CD8+ T lymphocytes, or B lymphocytes has different effects on the efficacy of posaconazole and benznidazole in treatment of experimental acute Trypanosoma cruzi infection.

Authors:  Marcela L Ferraz; Ricardo T Gazzinelli; Rosana O Alves; Julio A Urbina; Alvaro J Romanha
Journal:  Antimicrob Agents Chemother       Date:  2008-11-10       Impact factor: 5.191

2.  Experimental Chemotherapy for Chagas Disease: A Morphological, Biochemical, and Proteomic Overview of Potential Trypanosoma cruzi Targets of Amidines Derivatives and Naphthoquinones.

Authors:  Solange L de Castro; Denise G J Batista; Marcos M Batista; Wanderson Batista; Anissa Daliry; Elen M de Souza; Rubem F S Menna-Barreto; Gabriel M Oliveira; Kelly Salomão; Cristiane F Silva; Patricia B Silva; Maria de Nazaré C Soeiro
Journal:  Mol Biol Int       Date:  2011-06-30

Review 3.  Immunosuppression and Chagas disease: a management challenge.

Authors:  María-Jesús Pinazo; Gerard Espinosa; Cristina Cortes-Lletget; Elizabeth de Jesús Posada; Edelweiss Aldasoro; Inés Oliveira; Jose Muñoz; Montserrat Gállego; Joaquim Gascon
Journal:  PLoS Negl Trop Dis       Date:  2013-01-17

4.  Induction of resistance to azole drugs in Trypanosoma cruzi.

Authors:  F S Buckner; A J Wilson; T C White; W C Van Voorhis
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

Review 5.  Experimental and Clinical Treatment of Chagas Disease: A Review.

Authors:  Policarpo Ademar Sales Junior; Israel Molina; Silvane Maria Fonseca Murta; Adrián Sánchez-Montalvá; Fernando Salvador; Rodrigo Corrêa-Oliveira; Cláudia Martins Carneiro
Journal:  Am J Trop Med Hyg       Date:  2017-10-10       Impact factor: 2.345

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.